Yes, the data ought to be good enough for approval, but they're hardly earth-shattering. The trial was statsig on all efficacy endpoints because it was massively overpowered to show modest efficacy.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.